Where does Sungkwang Medical Foundation rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Sungkwang Medical Foundation ranks #16,401 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Sungkwang Medical Foundation hold?

Sungkwang Medical Foundation holds 18 US utility patents granted between 2016 and 2025, spanning 11 technology areas.

What is Sungkwang Medical Foundation's Innovation Score?

Sungkwang Medical Foundation has an Innovation Score of 45.2 out of 100 (top 24% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Sungkwang Medical Foundation's patent grant rate increasing or decreasing?

Sungkwang Medical Foundation's recent grant velocity is +100% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for Sungkwang Medical Foundation's patents?

Sungkwang Medical Foundation's patents average 5.6 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Sungkwang Medical Foundation patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Sungkwang Medical Foundation

Q: What technology areas does Sungkwang Medical Foundation focus on?

Sungkwang Medical Foundation's top technology area is C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media) with 13 patents, ranking #809 of 4,144 assignees active in that subclass. Grants appear in 11 CPC subclasses total.

USPTO PatentsView assignee record - 18 granted patents across 11 technology areas, recorded in grant years 2016–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Sungkwang ranks #16,401 of 49,997 tracked US assignees by granted-patent volume, with 18 patents across 11 technology areas.

#16,401
of 49,997 US assignees by volume: Top 24%
by Innovation Score (45.2/100): 5.6
avg claims per patent: +100%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R16401 · Foreign Corporation #16,401 · 18 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-SPARSE · TYPE-FRNCORP · VEL-SURGE · BOOK-FULL

GRANTS-MICRO 18 grants
MID-PACK #16,401/49,997
PHOTO-FINISH Sancal Diseño S L
CPC-FOCUS C12N · 11 areas
INNOV-PAR 45.2/100
CLAIMS-SPARSE 5.6 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-SURGE +100% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Sancal Diseño, S.L. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Sungkwang’s 45.2 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 10.2 pts (23%) Velocity 20.0 pts (44%) Breadth 11.7 pts (26%) Claim depth 3.3 pts (7%)

Qualcomm Incorporated · highest

85
Sungkwang Medical… · this assignee

45
3D Lighting… · lowest

7

What this shows Sungkwang's Innovation Score is 45.2/100 (top 24% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Sungkwang?

Each dot is one of Sungkwang’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Sungkwang’s own 5.6 claims/patent is at or below the 15.3 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Sungkwang vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Sungkwang's grants concentrate

Sungkwang Medical Foundation is a focused PatentsView assignee: 11 CPC subclasses with 72.2% of grants classified under C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media). Peak complete grant year is 2022 (5 grants) versus a trough of 1 in 2016. By volume, Sungkwang sits between Starconn Electronic (Su Zhou) Co., Ltd. and Sandvine Corporation.

Sungkwang's three-year grant acceleration

Sungkwang Medical Foundation shows 9 grants in 2022–2024 against only 1 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Starconn (Su Zhou)

18
Stiebel Eltron &…

18
Stmicroelectronic…

18
Stokes BIO

18
Surface Generation

18
Sword Health

18
Sancal Diseño S L

18
Sandvine

18
Sungkwang Medical… ◀

18

What this shows Sungkwang holds 18 patents at rank #16,355, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Sungkwang

By rank, the assignees closest to #16,355 in granted patent volume.

Leaders in C12N (Microorganisms OR Enzymes)

Other assignees with the most granted patents in Sungkwang's primary technology class.

Sungkwang's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

45 Top 24% higher than 76% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2016–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.

View data table

Sungkwang Medical Foundation patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2016	1	5.6%
2017	1	5.6%
2018	3	16.7%
2020	1	5.6%
2022	5	27.8%
2023	2	11.1%
2024	2	11.1%
2025partial year	3	16.7%

Which technologies does Sungkwang Medical Foundation patent most?

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 13

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 7

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 7

C12Q - Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes 6

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 5

C07D - Heterocyclic Compounds 3

A61Q - Specific USE OF Cosmetics OR Similar Toiletry Preparations 1

C12M - Apparatus FOR Enzymology OR MICROBIOLOGY; Apparatus FOR Culturing Microorganisms FOR Producing Biomass, FOR Growing Cells OR FOR Obtaining Fermentation OR Metabolic Products, i.e. Bioreactors OR Fermenters 1

A23L - Foods, Foodstuffs OR Non-alcoholic Beverages, NOT Otherwise Provided FOR; Preparation OR Treatment Thereof 1

A23V - Indexing Scheme Relating TO Foods, Foodstuffs OR Non-alcoholic Beverages AND Lactic OR Propionic Acid Bacteria Used IN Foodstuffs OR Food Preparation 1

A01N - Preservation OF Bodies OF Humans OR Animals OR Plants OR Parts Thereof ; Biocides, e.g. AS Disinfectants, AS Pesticides OR AS Herbicides ; Pest Repellants OR ATTRACTANTS; Plant Growth Regulators 1

Top 11 of 11 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Sungkwang Medical Foundation's patent record in context - here's where to go next.

Sungkwang Medical Foundation's lead technology class is C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media), 72.2% of its portfolio - see every assignee active in that class. Explore C12N
Ranked #16,401 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Sungkwang Medical Foundation against Starconn Electronic (Su Zhou) Co., Ltd., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 45.2/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.